TABLE 2.
Tissue examined | Viral titer in tissue at day p.i.a:
|
No. of latent viral genomes at day 30 p.i.b | ||
---|---|---|---|---|
3 | 5 | 7 | ||
Brain stem | 2.2 ± 0.3 (5) | 4.1 ± 0.1 (5) | 1.6 ± 0.1 (5) | 5.9 ± 0.1 (10) |
Cerebellum | 0.5 ± 0.3 (5) | 1.6 ± 0.3 (5) | 0.7 ± 0.3 (5) | 1.6 ± 0.4 (10) |
Olfactory bulbs | 0 (5) | 1.3 ± 0.5 (5) | 0 (5) | 3.9 ± 0.3 (6) |
Frontal cortex | 0 (5) | 0.5 ± 0.3 (5) | 0.3 ± 0.3 (5) | 4.2 ± 0.4 (6) |
Hippocampus | 0 (5) | 0.7 ± 0.5 (5) | 0 (5) | 3.2 ± 1.1 (6) |
BALB/c mice were infected with 2 × 107 PFU of HSV-1 strain KOS via both eyes, and brain tissues were harvested at indicated times p.i. for titration of virus. Results are expressed as the log10 mean PFU ± standard error of the mean/100 mg tissue for each group. Data were collected from at least two independent experiments, and the number of samples assayed for each group is indicated in parentheses.
At day 30 p.i., brain tissues were harvested and processed to quantify viral genomes by quantitative real-time PCR. Results are expressed as the log10 mean number of genomes ± standard error of the mean/μg DNA for each group. Data were collected from at least two independent experiments, and the number of samples assayed for each group is indicated in parentheses.